Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004–2012

References

• Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999;282:4140–6
   Web of Science ®Google Scholar
• Piñero Fernández JA, Alfayate Migueléz S, Menasalvas Ruiz A, et al. Características epidemiológicas, clínicas y terapéuticas de lactantes hospitalizados por bronquiolitis. Piñeiro. An Pediatr (Barc) 2012;77:391–6
   PubMed Web of Science ®Google Scholar
• World Health Organization. Respiratory syncytial virus and parainfluenza viruses. Geneva: WHO, 2009. Available at: http://www.who.int/vaccine_research/diseases/ari/en/index2.html [Last accessed 28 October 2014]
   Google Scholar
• Robinson J. Preventing respiratory syncytial virus infections. Paediatr Child Health 2011;16:487–90
   PubMed Web of Science ®Google Scholar
• Boyce TG, Mellen BG, Mitchel EF Jr, et al. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000;137:865–70
   PubMed Web of Science ®Google Scholar
• Marguet C, Lubrano M, Gueudin M, et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One 2009;4:e4596
   PubMed Web of Science ®Google Scholar
• Hervás D, Reina J, Yañez A, et al. Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis. Eur J Clin Microbiol Infect Dis 2012;31:1975–81
   PubMed Web of Science ®Google Scholar
• Díez-Domingo J, Pérez-Yarza EG, Melero JA, et al. Social, economic, and health impact of the respiratory syncytial virus: a systematic search. BMC Infect Dis 2014;14:544
   PubMed Web of Science ®Google Scholar
• Resch B. Respiratory syncytial virus infection in high-risk infants – an update on palivizumab prophylaxis. Open Microbiol J 2014;8:71–7
   PubMedGoogle Scholar
• Murray J, Bottle A, Sharland M, et al. Medicines for Neonates Investigator Group. Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS One 2014;9:e89186
   PubMed Web of Science ®Google Scholar
• Singleton RJ, Wirsing EA, Haberling DL, et al. Risk factors for lower respiratory tract infection death among infants in the United States, 1999–2004. Pediatrics 2009;124:e768–76
   PubMed Web of Science ®Google Scholar
• Nicolai A, Ferrara M, Schiavariello C, et al. Viral bronchiolitis in children: a common condition with few therapeutic options. Early Hum Dev 2013;89(Suppl 3):S7–11
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Tsugawa Y, Brown DF, et al. Trends in bronchiolitis hospitalizations in the United States, 2000–2009. Pediatrics 2013;132:28–36
   PubMed Web of Science ®Google Scholar
• Hospital Discharge Records Database. Minimum Basic Data Set (MBDS). Ministry of Health, 2012. Available at: http://www.msssi.gob.es/estadEstudios/estadisticas/cmbd.htm [Last accessed 10 October 2014]
   Google Scholar
• Hospital Discharge Records Database. Minimum Basic Data Set (MBDS). Glossary of terms and definitions. Health Information Institute [Instituto de Informacion Sanitaria, MSSSI], 2012. Available at: http://pestadistico.mspsi.es [Last accessed 10 October 2014]
   Google Scholar
• Hoopes JM, Kumar VN. Overview of respiratory syncytial virus disease in young children. Pediatr Health Med Therapeut 2012:3:45–50
   Google Scholar
• Figueras J, Quero J; Comité de Estándares de la Sociedad Española de Neonatología. Recomendaciones para la prevención de la infección por virus respiratorio sincitial. An Pediatr (Barc) 2005;63:357–62
   PubMedGoogle Scholar
• Summary Consensus RSV 2009. Cardio: Spanish Society of Pediatric Cardiology and Congenital Heart Disease. Available at: www.secardioped.org [Last accessed 21 June 2014]
   Google Scholar
• Gaboli M, de la Cruz ÒA, de Agüero MI, et al. Use of palivizumab in infants and young children with severe respiratory disease: a Delphi study. Pediatr Pulmonol 2014;49:490–502
   PubMed Web of Science ®Google Scholar
• Kristensen K, Hjuler T, Ravn H, et al. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clin Infect Dis 2012;54:810–17
   PubMed Web of Science ®Google Scholar
• Moreno-Perez D, Calvo C; Five Study Group. Epidemiological and clinical data of hospitalizations associated with respiratory syncytial virus infection in children under 5 years of age in Spain: FIVE multicenter study. Influenza Other Respir Viruses 2014;8:209–16
   PubMed Web of Science ®Google Scholar
• Stagliano DR, Nylund CM, Eide MB, Eberly MD. Children with Down syndrome are high-risk for severe respiratory syncytial virus disease. J Pediatr 2015;166:703–9.e2
   PubMed Web of Science ®Google Scholar
• Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 2009;94:99–103
   PubMed Web of Science ®Google Scholar
• Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997. J Infect Dis 2001;183:16–22
   PubMed Web of Science ®Google Scholar
• Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143(5 Suppl):S127–32
   PubMed Web of Science ®Google Scholar
• Rodríguez-Auad JP, Nava-Frías M, Casasola-Flores J, et al. The epidemiology and clinical characteristics of respiratory syncytial virus infection in children at a public pediatric referral hospital in Mexico. Int J Infect Dis 2012;16:e508–13
   PubMed Web of Science ®Google Scholar
• Salvador García C, Moreno Docón A, Piñero JA, et al. Aetiology of bronchiolitis in hospitalised children in South-East Spain. An Pediatr (Barc) 2012;77:386–90
   PubMed Web of Science ®Google Scholar
• Pons J. Infecciones de causa viral de las vías respiratorias bajas en la población pediátrica. Revisión sistemática de la bibliografía española. Plan de Calidad para el Sistema Nacional de Salud. Ministerio de Ciencia e Innovación. Informes de Evaluación de Tecnologías Sanitarias, AATRM núm. 2007/07. ISBN: 978-84-393-8072-6 2009. Madrid: Agènciad’Avaluació de Tecnologia i Recerca Mèdiques de Cataluña, 2009
   Google Scholar
• Byington CL, Wilkes J, Korgenski K, Sheng X. Respiratory syncytial virus–associated mortality in hospitalized infants and young children. Pediatrics 2015;135:e24–e31
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Anderson EJ, Simões EAF, et al. Respiratory syncytial virus disease in preterm infants in the US born at 32–35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J 2014;33:576–82
   PubMed Web of Science ®Google Scholar
• Committee on Infectious Diseases and Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014;134:e620–38
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Wang Y, Mattera JA, et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation 2006;113:1683–92
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association scientific statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group. Circulation 2006;113:456–62
   PubMed Web of Science ®Google Scholar
• Krumholz HM. Medicine in the era of outcomes measurement. Circ Cardiovasc Qual Outcomes 2009;2:141–3
   PubMed Web of Science ®Google Scholar
• Ross JS, Normand ST, Wang Y, et al. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med 2010;362:1110–18
   PubMed Web of Science ®Google Scholar